tradingkey.logo
tradingkey.logo
検索

Twist Bioscience Corp

TWST
ウォッチリストに追加
121.530USD
-21.050-14.76%
取引時間 11/05, 14:37(ET)
8.05B時価総額
損失額直近12ヶ月PER

Twist Bioscience Corpについて 企業名

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp プロフィール

企業コードTWST
会社名Twist Bioscience Corp
上場日Oct 31, 2018
最高経営責任者「CEO」Leproust (Emily M)
従業員数979
証券種類Ordinary Share
決算期末Oct 31
本社所在地681 Gateway Blvd.
都市SOUTH SAN FRANCISCO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94080
電話番号18007190671
ウェブサイトhttps://www.twistbioscience.com/
企業コードTWST
上場日Oct 31, 2018
最高経営責任者「CEO」Leproust (Emily M)

Twist Bioscience Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
107.19K
-47.52%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%

よくある質問

Twist Bioscience Corpの上位5名の株主は誰ですか?

Twist Bioscience Corpの上位5名の株主は以下のとおりです。Dr. Emily M. Leproust, Ph.D.

Twist Bioscience Corp(TWST)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Twist Bioscience Corpの株式を保有している機関は592社あり、保有株式の総市場価値は約78.48Mで、全体の126.03%を占めています。2025Q4と比較して、機関の持ち株は-339291.00増加しています。

Twist Bioscience Corpの最大の収益源は何ですか?

2026Q1において、NGS applications部門がTwist Bioscience Corpにとって最大の収益を生み出しており、その金額は61.80Mで、全収益の52.21%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。